Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,221
Closed -$7K 2163
2023
Q3
$7K Hold
3,221
﹤0.01% 2223
2023
Q2
$14K Hold
3,221
﹤0.01% 2209
2023
Q1
$14K Hold
3,221
﹤0.01% 2268
2022
Q4
$27K Buy
+3,221
New +$22.4K ﹤0.01% 2197
2022
Q2
Sell
-1,751
Closed -$11K 2429
2022
Q1
$11K Hold
1,751
﹤0.01% 2422
2021
Q4
$17K Hold
1,751
﹤0.01% 2402
2021
Q3
$187K Hold
1,751
﹤0.01% 1910
2021
Q2
$149K Buy
1,751
+7
+0.4% +$699 ﹤0.01% 1999
2021
Q1
$199K Buy
1,744
+206
+13% +$26K ﹤0.01% 1951
2020
Q4
$215K Hold
1,538
﹤0.01% 1950
2020
Q3
$125K Hold
1,538
﹤0.01% 1987
2020
Q2
$110K Hold
1,538
﹤0.01% 2020
2020
Q1
$68K Hold
1,538
﹤0.01% 2058
2019
Q4
$146K Buy
+1,538
New +$135K ﹤0.01% 1992
2019
Q3
Sell
-1,777
Closed -$77K 1150
2019
Q2
$77K Hold
1,777
﹤0.01% 2307
2019
Q1
$72K Hold
1,777
﹤0.01% 2168
2018
Q4
$89K Buy
+1,777
New +$89.1K ﹤0.01% 2183

Other funds holding ALLK

Canada Life's ALLK Position: Q4 2023 in Review

Canada Life sold out of Allakos (ALLK) in Q4 2023, closing a stake of 3,221 shares — an estimated $7K sold.

Canada Life first reported a position in ALLK in Q4 2018 and held it in 17 quarters. The position peaked at $215K in Q4 2020. 108 funds tracked by Wall St. Rank hold ALLK as of Q4 2023.

  • Canada Life reported no remaining Allakos position as of Q4 2023 after selling out during the quarter.
  • Canada Life sold 3,221 Allakos shares in Q4 2023, an estimated $7K.
  • Canada Life first reported a position in Allakos in Q4 2018 and held it in 17 quarters.
  • Canada Life's Allakos position peaked at $215K in Q4 2020.
  • 108 funds tracked by Wall St. Rank held Allakos as of Q4 2023.

Based on Canada Life's 13F filing for Q4 2023, filed 13 Feb 2024.